Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor
drops out
-
Pfizer’s announcement that it will stop developing its oral weight-loss
drug gave shares of Wegovy maker Novo Nordisk and Zepbound maker Eli Lilly
a lift.
48 minutes ago
US Government blocked 82 domain names of far-flung commercial websites to keep them from peddling counterfeit
ReplyDelete